Ference, B. A., Cannon, C. P., Landmesser, U., Lüscher, T. F., Catapano, A. L., & Ray, K. K. (2018). Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: An analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. Eur Heart J.

Ference, Brian A., Christopher P. Cannon, Ulf Landmesser, Thomas F. Lüscher, Alberico L. Catapano, a Kausik K. Ray. "Reduction of Low Density Lipoprotein-cholesterol and Cardiovascular Events With Proprotein Convertase Subtilisin-kexin Type 9 (PCSK9) Inhibitors and Statins: An Analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration." Eur Heart J 2018.

Ference, Brian A., et al. "Reduction of Low Density Lipoprotein-cholesterol and Cardiovascular Events With Proprotein Convertase Subtilisin-kexin Type 9 (PCSK9) Inhibitors and Statins: An Analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration." Eur Heart J 2018.